Factors affecting compliance and persistence with treatment for hepatic encephalopathy

Pharmacotherapy

Volumn 30, Issue 5 PART 2, 2010, Pages

  Neff, Guy ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Cirrhosis; Compliance; Hepatic encephalopathy; Medical adherence; Negative economic effects; Noncompliance; Prescriptions

Indexed keywords

LACTULOSE; NADOLOL; PLACEBO; PROPRANOLOL DERIVATIVE; RIFAXIMIN;

ABDOMINAL PAIN; CONFUSION; COST OF ILLNESS; DIARRHEA; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATIGUE; FLAPPING TREMOR; FLATULENCE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEALTH CARE PERSONNEL; HEPATIC ENCEPHALOPATHY; HOSPITAL ADMISSION; HOSPITAL COST; HOSPITALIZATION; HUMAN; LIVER CIRRHOSIS; MEDICATION ERROR; PATIENT COMPLIANCE; PRESCRIPTION; QUALITY OF LIFE; QUESTIONNAIRE; RECURRENT DISEASE; REVIEW; SOCIAL SUPPORT; TREATMENT RESPONSE;

DRUG COSTS; HEPATIC ENCEPHALOPATHY; HOSPITALIZATION; HUMANS; LACTULOSE; LIVER CIRRHOSIS; PATIENT COMPLIANCE; RIFAMYCINS;

EID: 77951730306     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.30.pt2.22S     Document Type: Review

References (18)

1. Bajaj JS. Management options for minimal hepatic encephalopathy. Expert Rev Gastroenterol Hepatol 2008;2:785-790
2. Poordad FF. Review article: the burden of hepatic encephalopathy. Aliment Pharmacol Ther 2007;25(suppl 1):3-9.
3. Busamante J, Rimola A, Ventura PJ, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999;30:890-895
4. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-497
5. Burnett-Bowie SA, McKay EA, Lee H, Leder BZ. Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels. J Clin Endocrinol Metab 2009;94:4785-4792
6. Standberg LR. Drugs as a reason for nursing home admissions. J Am Health Care Assoc 1984;10:20-23
7. Schering Laboratories. Schering report IX: the forgetful patient: the high cost of improper patient compliance. Available from http://www.cadexwatch. com/compliance.html. Accessed January 14, 2010.
8. Oregon Department of Human Resources. A study of longterm care in Oregon with emphasis on the elderly. 1981. Available from http://www.unitdose.org/ bibliography.htm. Accessed January 14, 2010.
9. National Council for Patient Information and Education. Educate before you medicate. Available from http://www.talkaboutrx.org. Accessed January 14, 2010.
10. Hayes RB. NCPIE prescription month, October 1989. Available from www.cadexwatch.com/compliance.html. Accessed January 14, 2010.
11. Velo GP, Minuz P. Medication errors: prescribing faults and prescription errors. Br J Clin Pharmacol 2009;67:624-628
12. Jones EA. Fatigue complicating chronic liver disease. Metab Brain Dis 2004;19:421-429 (Pubitemid 39361198)
13. Bajaj JS, Bell DE, Sanyal AJ, Gavis E, Heuman DM. Gastrointestinal adverse effects of lactulose can precipitate recurrent hepatic encephalopathy through non-compliance or overuse [abstract]. J Hepatol 2009;50(suppl 1):S74.
14. Leevy CB, Phillips JA. Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy. Dig Dis Sci 2007;52(3):737-741
15. Bass N, Mullen K, Sigal S, et al. Rifaximin is effective in maintaining remission in hepatic encephalopathy: results of a large, randomized, placebo-controlled trial [abstract]. J Hepatol 2009;50(suppl 1):S39.
16. Mullen K, Sigal S, Sheikh M, et al. Safety of rifaximin in patients with hepatic encephalopathy: results of a randomized, phase 3, placebo-controlled clinical trial. J Hepatol 2009;50 (suppl 1):S84-5.
17. Lebrec D, Poynard T, Capron JP, et al. Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial. J Hepatol 1988;7:118-125
18. Poynard T, Lebrec D, Hillon P, et al. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a prospective study of factors associated with rebleeding. Hepatology 1987;7:447-451 (Pubitemid 17073147)